{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T02:13:48Z","timestamp":1788488028238,"version":"build-2803163510"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100011324","name":"Qingdao University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011324","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jocn-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Neuroscience"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.jocn.2026.112216","type":"journal-article","created":{"date-parts":[[2026,7,26]],"date-time":"2026-07-26T13:27:43Z","timestamp":1785072463000},"page":"112216","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Association of lipoprotein-associated phospholipase A2 with recurrence risk and its predictive value in large artery atherosclerotic stroke"],"prefix":"10.1016","volume":"153","author":[{"given":"Qian","family":"Shao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zihan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingying","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anmu","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.jocn.2026.112216_b0005","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/S1474-4422(24)00369-7","article-title":"2021 Stroke Risk Factor Collaborators. Global, Regional, and National Burden of Stroke and its Risk Factors, 1990-2021: a Systematic Analysis for the Global Burden of Disease Study 2021","volume":"23","author":"GBD","year":"2024","journal-title":"Lancet Neurol"},{"issue":"4","key":"10.1016\/j.jocn.2026.112216_b0010","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1212\/01.WNL.0000110311.09970.83","article-title":"Early risk of recurrence by subtype of ischemic stroke in population-based incidence studies","volume":"62","author":"Lovett","year":"2004","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.jocn.2026.112216_b0015","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1002\/biof.1890","article-title":"Oxidized phospholipids and lipoprotein-associated phospholipase A(2) (Lp-PLA(2)) in atherosclerotic cardiovascular disease: an update","volume":"48","author":"Pantazi","year":"2022","journal-title":"Biofactors"},{"issue":"3","key":"10.1016\/j.jocn.2026.112216_b0020","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1089\/gtmb.2019.0162","article-title":"Association of serum lipoprotein-associated phospholipase A2 and A379V gene polymorphisms with carotid plaques","volume":"24","author":"Wu","year":"2020","journal-title":"Genet Test Mol Biomarkers"},{"issue":"1","key":"10.1016\/j.jocn.2026.112216_b0025","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1007\/s12012-024-09939-1","article-title":"Diagnostic utility of combining homocysteine, lipoprotein-associated phospholipase A2, and the C-reactive protein-to-albumin ratio for assessing carotid atherosclerosis and plaque stability in patients with essential hypertension","volume":"25","author":"Yuan","year":"2025","journal-title":"Cardiovasc Toxicol"},{"issue":"3","key":"10.1016\/j.jocn.2026.112216_b0030","doi-asserted-by":"crossref","DOI":"10.1002\/jcla.23084","article-title":"Evaluationof lipoprotein-associated phospholipase A2, Serum Amyloid A, and fibrinogen as diagnostic biomarkers for patients with acute cerebral infarction","volume":"34","author":"Tao","year":"2020","journal-title":"J Clin Lab Anal"},{"issue":"9","key":"10.1016\/j.jocn.2026.112216_b0035","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.medcli.2020.11.034","article-title":"The diagnostic and prognostic performance of Lp-Pla2 in acute ischemic stroke","volume":"156","author":"Li","year":"2021","journal-title":"Med Clin (Barc)"},{"issue":"5","key":"10.1016\/j.jocn.2026.112216_b0040","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1159\/000535286","article-title":"Causal effect of lipoprotein-associated phospholipase A2 activity on ischemic stroke: a mendelian randomization study","volume":"53","author":"Zhang","year":"2024","journal-title":"Cerebrovasc Dis"},{"issue":"2","key":"10.1016\/j.jocn.2026.112216_b0045","first-page":"317","article-title":"Serum lipoprotein-associated phospholipase A2 level is positively correlated with the recurrence risk of acute ischemic cerebral infarction in hypertensive patients","volume":"43","author":"Liang","year":"2023","journal-title":"Nan Fang Yi Ke Da Xue Xue Bao"},{"issue":"5","key":"10.1016\/j.jocn.2026.112216_b0050","doi-asserted-by":"crossref","first-page":"e729","DOI":"10.1016\/j.jacl.2024.04.133","article-title":"The joint association of lipoprotein(a) and lipoprotein-associated phopholipase A2 with the risk of stroke recurrence","volume":"18","author":"Xue","year":"2024","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.jocn.2026.112216_b0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.clineuro.2023.107899","article-title":"The Value of Serum Lp-PLA2 Combined with MPO in the diagnosis of cerebral infarction caused by large artery atherosclerosis","volume":"232","author":"Hua","year":"2023","journal-title":"Clin Neurol Neurosurg"},{"issue":"6","key":"10.1016\/j.jocn.2026.112216_b0060","doi-asserted-by":"crossref","first-page":"e3","DOI":"10.1136\/svn-2023-002998","article-title":"Chinese stroke association guidelines for clinical management of ischaemic cerebrovascular diseases: executive summary and 2023 update","volume":"8","author":"Liu","year":"2023","journal-title":"Stroke Vasc Neurol"},{"issue":"1","key":"10.1016\/j.jocn.2026.112216_b0065","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1161\/01.STR.24.1.35","article-title":"Classification of subtype of acute ischemic stroke. definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment","volume":"24","author":"Adams","year":"1993","journal-title":"Stroke"},{"issue":"12a","key":"10.1016\/j.jocn.2026.112216_b0070","doi-asserted-by":"crossref","first-page":"51f","DOI":"10.1016\/j.amjcard.2008.04.019","article-title":"Consensus panel recommendation for incorporating lipoprotein\u2011associated phospholipase A2 testing into cardiovascular disease risk assessment guidelines","volume":"101","author":"Davidson","year":"2008","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jocn.2026.112216_b0075","doi-asserted-by":"crossref","first-page":"81","DOI":"10.2147\/JIR.S447681","article-title":"Association of high\u2011sensitivity C\u2011reactive protein and lipoprotein\u2011associated phospholipase A2 with metabolically unhealthy phenotype: a cross sectional study","volume":"17","author":"Wang","year":"2024","journal-title":"J Inflamm Res"},{"issue":"6","key":"10.1016\/j.jocn.2026.112216_b0080","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.jstrokecerebrovasdis.2005.08.004","article-title":"Validity of a retrospective National Institutes of Health Stroke Scale scoring methodology in patients with severe stroke","volume":"14","author":"Lindsell","year":"2005","journal-title":"J Stroke Cerebrovasc Dis"},{"issue":"1","key":"10.1016\/j.jocn.2026.112216_b0085","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s11886-006-0003-4","article-title":"Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis","volume":"8","author":"Weinberger","year":"2006","journal-title":"Curr Cardiol Rep"},{"issue":"3","key":"10.1016\/j.jocn.2026.112216_b0090","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1161\/STROKEAHA.113.003508","article-title":"Prevalence and outcomes of symptomatic intracranial large artery stenoses and occlusions in China: the Chinese Intracranial Atherosclerosis (CICAS) Study","volume":"45","author":"Wang","year":"2014","journal-title":"Stroke"},{"issue":"4","key":"10.1016\/j.jocn.2026.112216_b0095","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.jphys.2022.05.017","article-title":"Clinimetrics: modified Rankin Scale (mRS)","volume":"68","author":"Haggag","year":"2022","journal-title":"J Physiotherapy"},{"issue":"4","key":"10.1016\/j.jocn.2026.112216_b0100","doi-asserted-by":"crossref","first-page":"e329","DOI":"10.1212\/WNL.0000000000013118","article-title":"Risks of stroke recurrence and mortality after first and recurrent strokes in Denmark: a nationwide registry study","volume":"98","author":"Skajaa","year":"2022","journal-title":"Neurology"},{"issue":"18","key":"10.1016\/j.jocn.2026.112216_b0105","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1212\/WNL.0000000000001938","article-title":"Association of Lp-PLA2-A and early recurrence of vascular events after TIA and minor stroke","volume":"85","author":"Lin","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.jocn.2026.112216_b0110","article-title":"Lipoprotein-associated phospholipase A2 (Lp-PLA2): a key hub linking lipid metabolism and immune inflammation","volume":"17","author":"Li","year":"2026","journal-title":"Front Immunol"},{"key":"10.1016\/j.jocn.2026.112216_b0115","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2021.642483","article-title":"Clinical utility of the serum level of lipoprotein-related phospholipase A2 in acute ischemic stroke with cerebral artery stenosis","volume":"12","author":"Cao","year":"2021","journal-title":"Frontiers In Neurology"},{"issue":"11","key":"10.1016\/j.jocn.2026.112216_b0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.jstrokecerebrovasdis.2024.108012","article-title":"Lipoprotein-Associated Phospholipase A(2) activity levels is associated with artery to artery embolism in symptomatic intracranial atherosclerotic disease","volume":"33","author":"Mo","year":"2024","journal-title":"J Stroke Cerebrovasc Dis"},{"issue":"24","key":"10.1016\/j.jocn.2026.112216_b0125","doi-asserted-by":"crossref","DOI":"10.1002\/jcla.25120","article-title":"Association of lipoprotein-associated phospholipase A2 and lipoprotein(a) with the risk of recurrence stroke in patients with acute ischemic stroke","volume":"38","author":"Feng","year":"2024","journal-title":"J Clin Lab Anal"},{"issue":"1","key":"10.1016\/j.jocn.2026.112216_b0130","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1159\/000172633","article-title":"Lipoprotein-associated phospholipase A2 activity and risk of recurrent stroke","volume":"27","author":"Elkind","year":"2009","journal-title":"Cerebrovasc Dis"},{"issue":"7","key":"10.1016\/j.jocn.2026.112216_b0135","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1080\/01616412.2024.2340886","article-title":"Correlation between plasma lipoprotein-associated phospholipase A2 levels and risk of ischaemic stroke recurrence by gender in the chinese population","volume":"46","author":"Huang","year":"2024","journal-title":"Neurol Res"},{"issue":"2","key":"10.1016\/j.jocn.2026.112216_b0140","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1159\/000334193","article-title":"Lipoprotein-Associated Phospholipase A(2) activity is associated with large-artery atherosclerotic etiology and recurrent stroke in tia patients","volume":"33","author":"Delgado","year":"2012","journal-title":"Cerebrovasc Dis"},{"issue":"5","key":"10.1016\/j.jocn.2026.112216_b0145","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1089\/jir.2024.0176","article-title":"Correlations of levels of peripheral blood inflammatory cytokines and serum lipoprotein-associated phospholipase-A(2) with acute ischemic stroke and their early prognostic value","volume":"45","author":"Zhong","year":"2025","journal-title":"J Interferon Cytokine Res"}],"container-title":["Journal of Clinical Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S096758682600367X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S096758682600367X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T01:45:21Z","timestamp":1788486321000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S096758682600367X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":29,"alternative-id":["S096758682600367X"],"URL":"https:\/\/doi.org\/10.1016\/j.jocn.2026.112216","relation":{},"ISSN":["0967-5868"],"issn-type":[{"value":"0967-5868","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association of lipoprotein-associated phospholipase A2 with recurrence risk and its predictive value in large artery atherosclerotic stroke","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Neuroscience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jocn.2026.112216","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"112216"}}